Canine placenta: a source of prepartal prostaglandins during normal and antiprogestin-induced parturition.
Expression of cyclooxygenase 2 (COX2, now known as PTGS2), prostaglandin E2 synthase (PTGES, PGES), and prostaglandin F2alpha synthase (PGFS), of the respective receptors PTGFR (FP), PTGER2 (EP2), and PTGER4 (EP4) and of the progesterone receptor (PGR, PR) was assessed by real-time PCR, immunohistochemistry (IHC), or in situ hybridization (ISH) in utero/placental tissue samples collected from three to five bitches on days 8-12 (pre-implantation), 18-25 (post-implantation), and 35-40 (mid-gestation) of pregnancy and during the prepartal luteolysis. Additionally, ten mid-pregnant bitches were treated with the antiprogestin aglepristone (10 mg/kg bw (2x/24 h)); ovariohysterectomy was 24 and 72 h after the second treatment. Plasma progesterone and 15-ketodihydro-PGF2alpha (PGFM) concentrations were determined by RIA. Expression of the PGR was highest before implantation and primarily located to the endometrium; expression in the placenta was restricted to the decidual cells. PTGS2 was constantly low expressed until mid-gestation; a strong upregulation occurred at prepartal luteolysis concomitant with an increase in PGFM. PGFS was upregulated after implantation and significantly elevated through early and mid-gestation. PTGES showed a gradual increase and a strong prepartal upregulation. PTGFR, PTGER2, and PTGER4 were downregulated after implantation; a gradual upregulation of PTGFR and PTGER2 occurred towards parturition. ISH and IHC co-localized PGFS, PTGFR, PTGES, and PTGS2 in the trophoblast and endometrium. The changes following application of aglepristone were in the same direction as those observed from mid-gestation to prepartal luteolysis. These data suggest that the prepartal increase of PGF2alpha results from a strong upregulation of PTGS2 in the fetal trophoblast with the withdrawal of progesterone having a signalling function and the decidual cells playing a key role in the underlying cell-to-cell crosstalk.
Kowalewski
Mariusz Pawel
MP
Clinic for Obstetrics, Gynecology and Andrology of Large and Small Animals, Justus-Liebig-University Giessen, 35392 Giessen, Germany. kowalewskipl@yahoo.de
Beceriklisoy
Hakki Bülent
HB
Pfarrer
Christiane
C
Aslan
Selim
S
Kindahl
Hans
H
Kücükaslan
Ibrahim
I
Hoffmann
Bernd
B
D000818:Animals; D015237:Dinoprost / Q000097:blood / Q000378:metabolism; D004285:Dogs / Q000378:metabolism / Q000502:physiology; D004963:Estrenes / Q000494:pharmacology; D005260:Female; D005865:Gestational Age; D006727:Hormone Antagonists / Q000494:pharmacology; D007751:Labor, Induced / Q000379:methods / Q000662:veterinary; D010120:Oxytocics / Q000494:pharmacology; D036801:Parturition / Q000097:blood / Q000187:drug effects / Q000378:metabolism* / Q000502:physiology; D010920:Placenta / Q000187:drug effects / Q000378:metabolism* / Q000502:physiology; D011247:Pregnancy; D011270:Pregnancy, Animal / Q000097:blood / Q000378:metabolism; D011374:Progesterone / Q000097:blood / Q000378:metabolism; D045167:Progesterone Congeners / Q000494:pharmacology; D011451:Prostaglandin-Endoperoxide Synthases / Q000235:genetics / Q000378:metabolism; D011453:Prostaglandins / Q000378:metabolism*; D011982:Receptors, Prostaglandin / Q000235:genetics / Q000378:metabolism
D004963:Estrenes; D006727:Hormone Antagonists; D010120:Oxytocics; D045167:Progesterone Congeners; D011453:Prostaglandins; D011982:Receptors, Prostaglandin; C419063:aglepristone; D011374:Progesterone; D015237:Dinoprost; D011451:Prostaglandin-Endoperoxide Synthases